Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

An Important Step in Discovering Biomarkers to Help Select the Right Cancer Treatment

An Important Step in Discovering Biomarkers to Help Select the Right Cancer Treatment

High cancer mortality reflects the lack of effective treatments and biomarkers assisting early diagnosis and treatment. Every newly discovered biomarker can therefore provide major benefits. In August 2016, the respected journal Nature Communicationspublished research identifying 14 genes important for predicting breast and lung cancer course .

Selecting the most appropriate treatment is a major challenge. Predicting an early-stage patient’s benefit from postoperative preventive (adjuvant) chemotherapy or radiotherapy can be difficult. Recent research in early-stage lung cancer found that, for 5-year survival, adjuvant chemotherapy contributes only around % 10.

Biomarkers are needed to prevent harsh, sometimes unnecessary treatment and guide correct decisions.

Exciting research comes from genetics. Researchers performed protein analysis of proteins managing genes. One of cancer’s 10 hallmarks is genomic instability, accumulating gene damage that disrupts function. Unequal distribution of genetic information during division is a major cause. The key structures ensuring equal distribution are centrosomes. Advanced tumor genetic analyses sought genes managing their function.

According to the Research Results,

  • Of 31 genes managing centrosome function, 14 had high activity in cancer cells.
  • Greater chromosome abnormalities—genomic instability—made cancer cells more sensitive to chemotherapy and radiotherapy.

However, no association with increased survival was found in patients not receiving adjuvant treatment.

What Does This Study Mean Clinically?

  • Genetic biomarkers provide more effective results than clinical and pathological ones. These analyses may predict treatment response in advance.

Cancer treatment works best multidisciplinarily. Basic sciences such as genetics and bioinformatics are increasingly important for selecting appropriate treatment.

Sources

Weiguo Zhang
Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy.
Nature Communications 7, 12619 (2016)

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

An Important Step in Discovering Biomarkers to Help Select the Right Cancer Treatment

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy